News
NUS researchers use magnetic pulses to turn cancer-promoting immune cells into cancer fighters
Summary by The Singapore Editorial Desk · As published by Straits Times — Singapore
· September 13, 2026
· 1 min read
Sources and story details Story provenance No corrections
Summary created by The Singapore Editorial Desk — automated, rule-governed Published by Straits Times — Singapore Original story Read at the source Source published Sep 13, 2026 Indexed here Sep 13, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points A Phase II clinical trial is underway to test the effectiveness of this treatment, known as PEMF. Researchers have made a breakthrough in cancer treatment by using magnetic pulses to transform cancer-promoting immune cells into cells that fight cancer.
Researchers have made a breakthrough in cancer treatment by using magnetic pulses to transform cancer-promoting immune cells into cells that fight cancer.
A Phase II clinical trial is underway to test the effectiveness of this treatment, known as PEMF. The trial aims to determine whether PEMF can shrink tumours and enhance the effects of chemotherapy in patients.
Further details about this innovative treatment and the clinical trial are available from the source, which reports on the ongoing research and its potential to improve cancer treatment outcomes.
More News Today’s briefing Local events
Frequently asked about this story
What is this story about? Researchers have made a breakthrough in cancer treatment by using magnetic pulses to transform cancer-promoting immune cells into cells that fight cancer. A Phase II clinical trial is underway to…
When was this published? This article was first published on September 13, 2026 by Straits Times — Singapore and curated for The Singapore readers.
Who reported this story? This story was reported by Straits Times — Singapore. To learn more about how The Singapore selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Singapore, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter